Lingrui Pharma (600285.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct29

Lingrui Pharma released FY2025 Q3 earnings on October 29 Pre-Market (BJT), actual revenue CNY 942.16 M, actual EPS CNY 0.3108

01:00

Lingrui Pharma released FY2025 9 Months Earnings on October 29 Pre-Market BJT, actual revenue CNY 3.041 B, actual EPS CNY 1.1447

01:00

Oct22

Lingrui Pharma to Release FY2025 Q3 Earnings Report on October 30, Pre-Market BJT

01:05

Aug19

Lingrui Pharma released FY2025 Q2 earnings on August 19 After-Market (BJT), actual revenue CNY 1.078 B, actual EPS CNY 0.4518

01:00

Lingrui Pharma released FY2025 Semi-Annual Earnings on August 19 After-Market (BJT), Actual Revenue CNY 2.099 B, Actual EPS CNY 0.834

01:00

Aug12

Lingrui Pharma to Release FY2025 Semi-Annual Earnings on August 20, 2025 (BJT)

00:10

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 942.16 M, Net Income 176.55 M, EPS 0.3108

Aug20

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug19

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 1.078 B, Net Income 257.57 M, EPS 0.4518

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More